Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Oblon, McClelland, Maier & Neustadt, L.L.P ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Specification Must Adequately Disclose The Claimed Invention To Avoid Invalidation For Lack Of Written Description
Claim 25 of Application No. 12/393,833, continued from the '803 application, also recited using random MPS to determine fetal aneuploidy.
United States
11 Sep 2019
2
Thinking Outside The (Utility Patent) Box – Don't Overlook Design Patent Protection In The Life Sciences
Design patents are very different from utility patents in that design patents only protect the ornamental features of an invention. In contrast to utility patents, the design is defined
United States
2 Sep 2019
3
Non-Limiting Clauses And Written Description Based On Substantially Equivalent Disclosure
Nalpropion Pharmaceuticals, Inc. v Actavis Laboratories FL, Inc (Fed. Cir. Aug. 15, 2019) is a precedential opinion written by Judge Lourie with Judge Wallach and a dissent from Judge Prost
United States
20 Aug 2019
5
Four Decisions Designated Informative On 101: Positive Trend For Life Sciences?
In January, 2019, the USPTO issued new guidance about what constitutes an abstract idea that is ineligible for protection under Section 101.
United States
5 Jul 2019
6
Written Description In Provisional Application: Perdue Pharma L.P. v. Andrei Iancu.
Amneal Pharmaceuticals, LLC. filed two petitions for inter partes review of claims 1–13 and 16–19 of U.S. Patent No. 9,034,376 of Purdue Pharma L.P., P.F. Laboratories, Inc. and Purdue Pharmaceuticals L.P.
United States
30 May 2019
7
What You Say Can Hurt You
Often in writing applications there is a tendency to denigrate prior art techniques.
United States
23 May 2019
8
Patent Strategy And the Internet Of Medical Things
James Love wrote an article entitled "Patent Strategy and The Internet of Medical Things," featured in Med Device Online.
United States
20 May 2019
9
Natural Alternatives - Claim Construction Defeats A 101 Challenge On The Pleadings
The district court's decision arouse out of a motion for judgment on the pleadings filed by Creative.
United States
27 Mar 2019
10
Biologic Patent Transparency Act - New Bill Aimed At Biologics
A bipartisan group of senators sponsored a bill this week—the Biologic Patent Transparency Act, S. 659—aimed at making patent information associated with biologics easier to identify and easing the approval process ...
United States
14 Mar 2019
12
The Federal Circuit Still Doesn't Get Diagnostic Claims
In Roche Diagnostics the Federal Circuit continued its failure to recognize that diagnostic claims were not patent ineligible because they used a natural law.
United States
13 Dec 2018
13
SAS Affects Use Of Disclaimer To Obtain Motion To Dismiss
The Board agreed with petitioner LG and denied patent owner Wi-Lan's motion to dismiss.
United States
7 Dec 2018
14
Obviousness Of A Dosage Regiment: Yeda Research And Development Co., Ltd. v. Mylan Pharmaceuticals Inc. Teva Pharmaceuticals USA, Inc. v. Sandoz Inc
The Board next considered whether there was a motivation to modify Pinchasi's 40mg every other day regimen.
United States
4 Dec 2018
15
Hedge Your Bets In TC 1600 PGRs
Post grant reviews (PGRs) have proven to be more popular in the biotechnology space (TC 1600) than any other art unit, with 42—or 28.1%—of the PGRs filed to date classified as TC 1600 patents.
United States
4 Dec 2018
16
The Internet Of Medical Things (IoMT) In The World Of Medical Devices
The Internet of Medical Things (IoMT) is a hot topic in the world of medical devices. This summer, at the MedTech conference in Philadelphia, IoMT was the word on everyone's lips.
United States
21 Nov 2018
17
USPTO Releases Interim Procedure For Requesting Recalculation Of Patent Term Adjustment Related To The IDS Safe Harbor
On Friday, November 2, 2018, the USPTO released its interim procedure for patentees to request recalculation of the patent term adjustment with respect to information disclosure statements accompanied by ...
United States
14 Nov 2018
18
IP Strategies For Medical Device Technologies: Be Your Own Incubator
The book is an essential resource for inventors, attorneys, IP professionals, or anyone with an interest in medical device IP for understanding the nuances of protecting and launching a medical...
United States
31 Oct 2018
19
Federal Circuit Reiterates That Naturally-Occurring Nucleotide Sequences Are Not Patent Eligible Under 35 U.S.C. § 101
On October 9, 2018, in Roche Molecular Systems, Inc. v. Cepheid, the Federal Circuit upheld a district court decision that claims reciting nucleotide primers in U.S. Patent No. 5,643,723...
United States
16 Oct 2018
20
Final Rule Change Replacing BRI With Phillips Standard
Effective November 13th, all claims challenged in IPR, PGR, and CBM petitions will be interpreted under Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc).
United States
12 Oct 2018
Links to Result pages
 
1 2  
>>Next